Olokizumab
Olokizumab is a humanized monoclonal antibody designed for the treatment of Rheumatoid arthritis. It is developed by R-Pharm and UCB.
Mechanism of Action[edit]
Olokizumab works by targeting and inhibiting the IL-6 cytokine, a protein that plays an important role in the inflammatory response of the immune system. By blocking the action of IL-6, Olokizumab can reduce inflammation and slow the progression of rheumatoid arthritis.
Clinical Trials[edit]
Olokizumab has undergone Phase III clinical trials for the treatment of rheumatoid arthritis. The trials have shown that Olokizumab is effective in reducing the symptoms of rheumatoid arthritis and improving the quality of life for patients.
Side Effects[edit]
Like all medications, Olokizumab can cause side effects. The most common side effects reported in clinical trials include upper respiratory tract infections, nasopharyngitis, and injection site reactions.
Approval[edit]
Olokizumab has been approved for use in Russia and is currently under review by the EMA and the FDA in the United States.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
| This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
